CMS Approved HBOT Indications
The following list details the current CMS approved and reimbursable indications for Hyperbaric Oxygen Therapy (HBOT). HBOT is covered as adjunctive therapy only after there are no measurable signs of healing for at least 30 days of treatment with standard wound therapy and must be used in addition to standard wound care. Standard wound care in patients with diabetic wounds includes: assessment of a patient's vascular status and correction of any vascular problems in the affected limb if possible, optimization of nutritional status, optimization of glucose control, debridement by any means to remove devitalized tissue, maintenance of a clean, moist bed of granulation tissue with appropriate moist dressings, appropriate off-loading, and necessary treatment to resolve any infection that might be present. Failure to respond to standard wound care occurs when there are no measurable signs of healing for a least 30 consecutive days. Wounds must be evaluated at least every 30 days during HBOT. Below are the 15 CMS and most 3rd Party Payors approved and reimbursable indications for HBOT which range from the critical care inpatient to the ambulatory care self referral:
(You Can Click Any Indication To Learn More About The Condition)
